We’re thrilled to announce that our brand-new Physical Therapy Clinic in Ballston, Arlington, VA will officially open on ...
Revolution Medicines shows RAS drug optimism with phase 3 catalysts, early-stage valuation, buyout chatter, and competition ...
Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing next-generation targeted therapies for patients with immune-mediated diseases, today announced the closing of its ...
Mild hidradenitis suppurativa is often treated with cycles of steroids and antibiotics that have adverse effects. Can an anti ...
Being a mom means the world to Ashley Tisdale, and she enjoys it despite facing complicated pregnancies and struggling with ...
The Healthy @Reader's Digest on MSN
People whose toes can do this one thing might actually live longer, says a foot researcher
"Almost no footwear" today supports it, says this gait specialist, who explains the aha! connection between the feet and ...
While the early 2020s were dominated by the soft aesthetics of reparenting our toddlers, 2026 has ushered in a much grittier ...
It’s CES 2026 week! That means more product launches than anyone knows what to do with. But that’s exactly why you read CNN Underscored — we combed the web (and the Las Vegas showroom floor) to find ...
In addition, Alumis has granted the underwriters a 30-day option to purchase up to an additional 2,647,500 shares of common stock at the public offering price, less underwriting discounts and ...
Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing next-generation targeted therapies for patients with immune-mediated diseases, today announced its plans to commence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback